Search
for
Sort by
Research 571–600 of 1000+
- Trichoscopic Features, Clinical Correlates, and Risk Prediction in Female Pattern Hair Loss: A Retrospective Case-Control Study
- Perifollicular Inflammation and Fibrosis in Androgenetic Alopecia: Implications for Diagnosis and Treatment - A Comparative Histopathologic and Clinical Study with Normal-Appearing Scalp
- Heterozygous Variants of the SLC39A4 Gene and Possible Increased Risk for Developing Acrodermatitis Enteropathica with Kaposi’s Varicelliform Eruption
- Study of Association of Dyslipidemia in Male Androgenetic Alopecia Patients in a Tertiary Care Hospital
- Prostate cancer and androgenic alopecia: The role of finasteride as a dual agent
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia
- Diffused alopecia followed by severe acute respiratory syndrome coronavirus-2 infection
- Prevalence of Androgenetic Alopecia among Saudi Population
- Role of polymorphism of the androgen receptor gene andnon-random x chromosome inactivation in the pathogenesisof androgenic alopecia
- Cutaneous signs in COVID ‐19 patients: A review
- Telogen effluvium
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Primary cicatricial alopecia: diagnosis and treatment
- Overexpression of Bcl-2 Protects from Ultraviolet B-Induced Apoptosis but Promotes Hair Follicle Regression and Chemotherapy-Induced Alopecia
- Practical Guidelines for Evaluation of Loose Anagen Hair Syndrome
- SYK inhibitor entospletinib prevents ocular and skin GVHD in mice
- Adverse Cutaneous Reactions to Antidepressants
- Primary Cicatricial Alopecias
- Hair and nail involvement in lupus erythematosus
- Histopathological insights into hair loss in Cronkhite-Canada syndrome: Diffuse anagen-telogen conversion precedes clinical hair loss progression
- Dermatologic Reactions to Targeted Therapy
- Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.
- Reversible alopecia in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia
- Break Dancing: A New Risk Factor for Scarring Hair Loss
- Expanding on the phenotypic spectrum of Woodhouse‐Sakati syndrome due to founder pathogenic variant in <i>DCAF17</i>: Report of 58 additional patients from Qatar and literature review
- Frontal fibrosing alopecia: a disease that remains enigmatic
- Central Centrifugal Cicatricial Alopecia in the Adolescent Population: An Overview of Available Literature
- Cancer-Related Alopecia: From Etiologies to Global Management
- 67 Patterns of clinical response in patients with alopecia areata (AA) treated with ritlecitinib in the ALLEGRO phase 2b/3 and ongoing, phase 3, ALLEGRO-LT studies